Molecular subtyping of breast cancer: opportunities for new therapeutic approaches.
Evidence is accumulating that breast cancer is not one disease but many separate diseases. DNA microarray-based gene expression profiling has demonstrated subtypes with distinct phenotypic features and clinical responses. Prominent among the new subtypes is 'basal-like' breast cancer, one of the 'intrinsic' subtypes defined by negativity for the estrogen, progesterone, and HER2/neu receptors and positivity for cytokeratins-5/6. Focusing on basal-like breast cancer, we discuss how molecular technologies provide new chemotherapy targets, optimising treatment whilst sparing patients from unnecessary toxicity. Clinical trials are needed that incorporate long-term follow-up of patients with well-characterised tumour markers. Whilst the absence of an obvious dominant oncogene driving basal-like breast cancer and the lack of specific therapeutic agents are serious stumbling blocks, this review will highlight several promising therapeutic candidates currently under evaluation. Thus, new molecular technologies should provide a fundamental foundation for better understanding breast and other cancers which may be exploited to save lives. (Part of a Multi-author Review).
Mullan
P B
PB
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK. p.mullan@qub.ac.uk
Millikan
R C
RC
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D002986:Clinical Trials as Topic; D005557:Formaldehyde / Q000494:pharmacology; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D019398:Genes, BRCA1; D006801:Humans; D008954:Models, Biological; D025202:Molecular Diagnostic Techniques; D018295:Neoplasms, Basal Cell / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis
D000970:Antineoplastic Agents; D005557:Formaldehyde